Our history

 1992:  First MagPro stimulator hits the market (sold under the Dantec brand)

2001: MagVenture introduces the cost-effective Static Cool concept, allowing TMS researchers to run protocols without changing coils in the middle of sessions.

2004: MagVenture takes coil cooling to a new level with the Dynamic Cool concept, allowing TMS researchers to perform consecutive rTMS treatments without coil change.

2007: MagVenture is officially established under its own name.

2010: Subsidiary MagVenture Inc. is established in the US.

2010: MagVenture launches a complete rTMS research system, including a coil for double-blinded placebo-trials.

2011: MagVenture is the first TMS provider to receive CE approval for its depression treatment system known as MagVita TMS Therapy, now named MagVenture TMS Therapy.

2011: Subsidiary MagVenture GmbH is established in Germany.

2013: Researchers can now perform rTMS inside an MRi scanner with the new Mri-B91 coil from MagVenture: 


2014: A new coil for stimulating rodents sees the light of day, providing a valuable tool for animal model research.

2014:  The MagPro R20 is released, a taylormade solution for smaller start-up practices.
The Cool B91 coil is for so-called interleaved TMS in an MRi Tesla scanner.

2015: MagVenture receives FDA clearance for the treatment of major depressive disorder. 

2017: Sales Subsidiary MagVenture Ltd., located in Reading just outside London, is established in the UK:

2018: The world’s largest Randomized Control Trial with TMS to date is published [Blumberger et al, 2018, The Lancet].  
2018: MagVenture’s brings the MagPro XP to the market, an extremely powerful solution for high-end research involving fields within the neurophysiology range as well as MRi.
2018: Besides subsidiaries in the US, Germany and the United Kingdom, MagVenture is now also represented in 50+ countries. MagVenture also launches a new, dark blue logo: 

This video also gives an overview of who we are and what we stand for: